Inventor · disambiguated record
James Mcswiggen
Also filed as: MCSWIGGEN JAMES · MCSWIGGEN JAMES A · MCSWIGGEN JAMES ANTHONY
118 granted patents·253 pending applications·4,200 citations·filing 1994–2022
99Inventor score
Files withSIRNA THERAPEUTICS INC184RIBOZYME PHARM INC39MCSWIGGEN JAMES18MERCK SHARP & DOHME16MDRNA INC9
Top patents by PatentIndex Score
371 records- 0199US10000754B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Jun 19, 2018·35 cites·21 claims
- 0299US9771588B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·44 cites·52 claims
- 0399US9732344B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2016·Granted Aug 15, 2017·43 cites·29 claims
- 0499US9657294B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted May 23, 2017·36 cites·23 claims
- 0599US9181551B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·102 cites·82 claims
- 0699US8846894B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)MCSWIGGEN JAMES·Filed 2007·Granted Sep 30, 2014·42 cites·24 claims
- 0799US8202979B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acidMCSWIGGEN JAMES·Filed 2003·Granted Jun 19, 2012·106 cites·9 claims
- 0899US7176304B2RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)MCSWIGGEN JAMES·Filed 2004·Granted Feb 13, 2007·187 cites·2 claims
- 0998US8618277B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)BEIGELMAN LEONID·Filed 2012·Granted Dec 31, 2013·87 cites·4 claims
- 1098US8273866B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)MCSWIGGEN JAMES·Filed 2003·Granted Sep 25, 2012·100 cites·12 claims
- 1198US8268986B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)BEIGELMAN LEONID·Filed 2011·Granted Sep 18, 2012·54 cites·5 claims
- 1298US7989612B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Granted Aug 2, 2011·36 cites·10 claims
- 1398US7923547B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Granted Apr 12, 2011·82 cites·3 claims
- 1498US6673611B2Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionSIRNA THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·218 cites·17 claims
- 1598US5972704AHIV nef targeted ribozymesRIBOZYME PHARM INC·Filed 1997·Granted Oct 26, 1999·221 cites·22 claims
- 1697US8242257B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)BEIGELMAN LEONID·Filed 2011·Granted Aug 14, 2012·29 cites·5 claims
- 1797US7956176B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Granted Jun 7, 2011·42 cites·14 claims
- 1897US7022828B2siRNA treatment of diseases or conditions related to levels of IKK-gammaSIRNA THERAPUTICS INC·Filed 2002·Granted Apr 4, 2006·186 cites·16 claims
- 1996US8236944B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)BEIGELMAN LEONID·Filed 2011·Granted Aug 7, 2012·21 cites·5 claims
- 2096US6566127B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorRIBOZYME PHARM INC·Filed 1999·Granted May 20, 2003·141 cites·5 claims
- 2196US6346398B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorRIBOZYME PHARM INC·Filed 1996·Granted Feb 12, 2002·245 cites·23 claims
- 2295US10662428B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2019·Granted May 26, 2020·5 cites·4 claims
- 2395US7795422B2RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2008·Granted Sep 14, 2010·15 cites·5 claims
- 2495US7034009B2Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)CHIRON CORP·Filed 2002·Granted Apr 25, 2006·49 cites·20 claims
- 2595US6818447B1Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptorSIRNA THERAPEUTICS INC·Filed 2000·Granted Nov 16, 2004·49 cites·12 claims
- 2695US5877022ARibozymes targeted to APO(a) RNARIBOZYME PHARM INC·Filed 1996·Granted Mar 2, 1999·167 cites·20 claims
- 2795US5631359AHairpin ribozymesRIBOZYME PHARM INC·Filed 1994·Granted May 20, 1997·268 cites·15 claims
- 2894US8232383B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)MCSWIGGEN JAMES·Filed 2008·Granted Jul 31, 2012·27 cites·9 claims
- 2993US10351852B2RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2017·Granted Jul 16, 2019·5 cites·47 claims
- 3093US10059941B2Compositions and methods for modulating SMN gene family expressionTRANSLATE BIO MA INC·Filed 2013·Granted Aug 28, 2018·13 cites·38 claims
- 3193US5646042AC-myb targeted ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Jul 8, 1997·123 cites·220 claims
- 3292US10174323B2Compositions and methods for modulating ATP2A2 expressionTRANSLATE BIO MA INC·Filed 2013·Granted Jan 8, 2019·11 cites·31 claims
- 3392US7935812B2RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)MERCK SHARP & DOHME·Filed 2009·Granted May 3, 2011·28 cites·13 claims
- 3491US8013143B2RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)MERCK SHARP & DOHME·Filed 2008·Granted Sep 6, 2011·11 cites·10 claims
- 3591US7977472B2RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)BEIGELMAN LEONID·Filed 2010·Granted Jul 12, 2011·16 cites·5 claims
- 3691US5877021AB7-1 targeted ribozymesRIBOZYME PHARM INC·Filed 1996·Granted Mar 2, 1999·88 cites·11 claims
- 3790US7910724B2RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2008·Granted Mar 22, 2011·6 cites·5 claims
- 3890US6022962AHairpin ribozymesRIBOZYME PHARMACEUTICAL INC·Filed 1998·Granted Feb 8, 2000·99 cites·12 claims
- 3990US5891684ABase-modified enzymatic nucleic acidRIBOZYME PHARM INC·Filed 1994·Granted Apr 6, 1999·91 cites·38 claims
- 4089US5525468AAssay for Ribozyme target siteRIBOZYME PHARM INC·Filed 1994·Granted Jun 11, 1996·122 cites·15 claims
- 4188US8614309B2Double-stranded RNA directed to CASP2 and methods of use thereofFEINSTEIN ELENA·Filed 2008·Granted Dec 24, 2013·11 cites·34 claims
- 4288US7915400B2RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)MERCK SHARP & DOHME·Filed 2008·Granted Mar 29, 2011·10 cites·5 claims
- 4388US7897752B2RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2008·Granted Mar 1, 2011·7 cites·5 claims
- 4487US7956178B2RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acid (siNA)MCSWIGGEN JAMES·Filed 2009·Granted Jun 7, 2011·5 cites·5 claims
- 4587US7855284B2RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2009·Granted Dec 21, 2010·5 cites·10 claims
- 4687US7659389B2RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2008·Granted Feb 9, 2010·5 cites·19 claims
- 4787US6350934B1Nucleic acid encoding delta-9 desaturaseRIBOZYME PHARM INC·Filed 1996·Granted Feb 26, 2002·89 cites·11 claims
- 4887US5811300ATNF-α ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Sep 22, 1998·95 cites·13 claims
- 4986US10655128B2Compositions and methods for modulating MECP2 expressionTRANSLATE BIO MA INC·Filed 2017·Granted May 19, 2020·4 cites·16 claims
- 5086US7700760B2RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2008·Granted Apr 20, 2010·6 cites·19 claims
Showing the top 50 of 371 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →